Contributions of Transesophageal Echocardiography in Liver Transplant Surgery

Sponsor
Hospital Universitari Vall d'Hebron Research Institute (Other)
Overall Status
Completed
CT.gov ID
NCT05175534
Collaborator
(none)
32
2
52.3
16
0.3

Study Details

Study Description

Brief Summary

The goal of this study is to describe the safety and impact of transesophageal echocardiography in instability episodes during liver transplantation, especially during reperfusion stage.

After institutional review board approval, this study was performed in Vall d´Hebron

University Hospital including patients undergoing liver transplantation Interventions:

peroperative transesophageal echocardiography A transesophageal echocardiography scan was performed in case of hemodynamic instability episodes, and immediately after vascular unclamping.

The investigators registered percentatge of patients with diastolic/systolic dysfunction, hypovolemia, vasodilatation, embolism and percentatge of patients with postreperfusion syndrome

Condition or Disease Intervention/Treatment Phase
  • Procedure: monitoring

Detailed Description

A TEE scan was performed in case of hemodynamic instability episodes defined by a decrease of 30% of the mean arterial pressure (MAP) during at least 1 min, and in all patients during immediate graft reperfusion phase and up 30 minutes.

The instability hemodynamic state was classified into four categories: diastolic failure, systolic failure, hypovolemia and vasodilatation.

The diastolic evaluation was performed at ME 4C view using pulsed doppler of the mitral and tricuspid valve at the level of the leaflet tips and tissue Doppler motion of the mitral and tricuspid annulus. The systolic evaluation was performed using tissue Doppler motion of the mitral and tricuspid annulus evaluating S´. Hypovolemia was registered such low filling pressures (mitral lateral E/e´<10 m/s), cardiac index < 2.5 l . min-1 . m-2 and close approximation of the papillary muscles in the TG Mid SAX view. Vasodilatation was registered such low filling pressures (mitral E/e´< 10 m/s) and CI >2.5 l. min-1 . m-2).

An assessment of cardiac filling volumes and contractility, were obtained at two levels: the mid-esophageal four-chamber view (ME 4C) to evaluate the interaction of left and right ventricles and detect possible venous air embolism; and in the trans-gastric mid short axis view (TG mid SAX), to evaluate left ventricular size for the diagnosis of hypovolemia secondary to hemorrhage or altered venous return due to surgical maneuvers on the liver, and segmental wall motion. If the TG mid SAX view was not possible due to the posterior retraction of the stomach during surgery, the ME 4C view, mid-esophageal two chamber view (ME 2C) and mid-esophageal long axis view (ME LAX) was used for the diagnosis of left ventricle systolic dysfunction, and mid-esophageal bicaval view (ME bicaval) was used for the volemia evaluation.

Study Design

Study Type:
Observational
Actual Enrollment :
32 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Contributions of Transesophageal Echocardiography During Episodes of Hemodynamic Instability in Liver Transplant Surgery
Actual Study Start Date :
Jan 30, 2016
Actual Primary Completion Date :
May 10, 2020
Actual Study Completion Date :
Jun 10, 2020

Outcome Measures

Primary Outcome Measures

  1. determine the cardiac alterations observed during reperfusion phase [during liver transplant]

    relationship between cardiac dysfunction and development of post reperfusion syndrome

Secondary Outcome Measures

  1. determine the cardiac alterations during episodes of hemodynamic instability [during liver transplant]

    hemodynamic instability was defined as a decrease in the mean arterial pressure (MAP) ≥ 30% from baseline

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria: patients undergoing liver transplantation

-

Exclusion Criteria:
  • None

Contacts and Locations

Locations

Site City State Country Postal Code
1 Susana González Suárez Barcelona Cataluña Spain 08035
2 Vall d´Hebron Research Institute VHIR Barcelona Spain 08035

Sponsors and Collaborators

  • Hospital Universitari Vall d'Hebron Research Institute

Investigators

  • Principal Investigator: Susana González-Suárez, MD, PhD, Vall d´Hebron University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hospital Universitari Vall d'Hebron Research Institute
ClinicalTrials.gov Identifier:
NCT05175534
Other Study ID Numbers:
  • PR(AG)511/2019
First Posted:
Jan 3, 2022
Last Update Posted:
Jan 3, 2022
Last Verified:
Dec 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 3, 2022